Vol. 1 - Pages 9.1-9.30 (Printed Version) - Tabl* 9.3
Reproductive System
STRUCTURE OF THE FEMALE
REPRODUCTIVE SYSTEM AND TARGET ORGAN
VULNERABILITY
Potential female reproductive toxicants
|
Compound |
Clinical manifestation |
Site |
Mechanism/target |
|
Chemical reactivity |
|||
|
Alkylating |
Altered menses |
Ovary |
Granulosa cell cytotoxicity |
|
Lead |
Abnormal menses |
Hypothalamus |
Decreased FSH |
|
Mercury |
Abnormal menses |
Hypothalamus |
Altered gonadotrophin production and secretion |
|
Cadmium |
Follicular atresia |
Ovary |
Vascular toxicity |
|
Structural similarity |
|||
|
Azathioprine |
Reduced follicle numbers |
Ovary |
Purine analog |
|
Chlordecone |
Impaired fertility |
Hypothalamus |
Oestrogen agonist |
|
DDT |
Altered menses |
Pituitary |
FSH, LH disruption |
|
2,4-D |
Infertility |
|
|
|
Lindane |
Amenorrhoea |
|
|
|
Toxaphene |
Hypermenorrhoea |
|
|
|
PCBs, PBBs |
Abnormal menses |
|
FSH, LH disruption |
Source: From Plowchalk, Meadows and Mattison 1992. These compounds
are suggested
to be direct-acting reproductive toxicants based primarily on toxicity testing
in
experimental animals.